Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
AIDS and Behavior
Published in: AIDS and Behavior 11/2019

01-11-2019 | Human Immunodeficiency Virus | Original Paper

VITAL Start: Video-Based Intervention to Inspire Treatment Adherence for Life—Pilot of a Novel Video-Based Approach to HIV Counseling for Pregnant Women Living with HIV

Authors: Maria H. Kim, Saeed Ahmed, Tapiwa Tembo, Rachael Sabelli, Robert Flick, Xiaoying Yu, Alick Mazenga, Holly Le Blond, Katie Simon, Miriam Hartig, Elizabeth Wetzel, Rose Nyirenda, Peter N. Kazembe, Mtisunge Mphande, Angella Mkandawire, Mike J. Chitani, Elaine J. Abrams

Published in: AIDS and Behavior | Issue 11/2019

Login to get access

Abstract

We developed and piloted a video-based intervention targeting HIV-positive pregnant women to optimize antiretroviral therapy (ART) retention and adherence by providing a VITAL Start (Video-intervention to Inspire Treatment Adherence for Life) before ART. VITAL Start (VS) was grounded in behavior-determinant models and developed through an iterative multi-stakeholder process. Of 306 pregnant women eligible for ART, 160 were randomized to standard of care (SOC), 146 to VS and followed for one-month. Of those assigned to VS, 100% completed video-viewing; 96.5% reported they would recommend VS. Of 11 health workers interviewed, 82% preferred VS over SOC; 91% found VS more time-efficient. Compared to SOC, VS group had greater change in HIV/ART knowledge (p < 0.01), trend towards being more likely to start ART (p = 0.07), and better self-reported adherence (p = 0.02). There were no significant group differences in 1-month retention and pharmacy pill count. VITAL Start was highly acceptable, feasible, with promising benefits to ART adherence.
Literature
1.
Joint United Nations Programme on HIV/AIDS. Ending AIDS: progress towards the 90–90–90 targets. Geneva: Joint United Nations Programme on HIV/AIDS; 2017.
2.
3.
Joint United Nations Programme on HIV/AIDS. On the Fast-Track to an AIDS-free generation. Geneva: Joint United Nations Programme on HIV/AIDS; 2016.
4.
Chersich MF, Newbatt E, Ng’oma K, de Zoysa I. UNICEF’s contribution to the adoption and implementation of option B+ for preventing mother-to-child transmission of HIV: a policy analysis. BMC Glob Health. 2018;14(1):55.CrossRef
5.
Adakun SA, Siedner MJ, Muzoora C, et al. Higher baseline CD4 cell count predicts treatment interruptions and persistent viremia in patients initiating ARVs in rural Uganda. J Acquir Immune Defic Syndr. 2013;62(3):317–21.PubMedPubMedCentralCrossRef
6.
Haas AD, Msukwa MT, Egger M, et al. Adherence to antiretroviral therapy during and after pregnancy: cohort Study on women receiving care in Malawi’s Option B+ Program. Clin Infect Dis. 2016;63(9):1227–35.PubMedPubMedCentral
7.
The INSIGHT Start Study Group. Initiation of antiretroviral therapy in early asymptomatic HIV infection. N Engl J Med. 2015;373(9):795–807.PubMedCentralCrossRef
8.
9.
Tenthani L, Haas AD, Tweya H, et al. Retention in care under universal antiretroviral therapy for HIV infected pregnant and breastfeeding women (“Option B+”) in Malawi. AIDS. 2014;28(4):589–98.PubMedCrossRef
10.
Tweya H, Gugsa S, Hosseinipour M, et al. Understanding factors, outcomes and reasons for loss to follow-up among women in Option B+ PMTCT programme in Lilongwe, Malawi. Trop Med Int Health. 2014;19(11):1360–6.PubMedCrossRef
11.
Napua M, Pfeiffer JT, Chale F, et al. Option B+ in Mozambique: formative research findings for the design of a facility-level clustered randomized controlled trial to improve ART retention in antenatal care. J Acquir Immune Defic Syndr. 2016;72(Suppl 2):S181–8.PubMedPubMedCentralCrossRef
12.
Puttkammer N, Domercant JW, Adler M, et al. ART attrition and risk factors among Option B+ patients in Haiti: a retrospective cohort study. PLoS ONE. 2017;12(3):e0173123.PubMedPubMedCentralCrossRef
13.
Okawa S, Chirwa M, Ishikawa N, et al. Longitudinal adherence to antiretroviral drugs for preventing mother-to-child transmission of HIV in Zambia. BMC Pregn. Childbirth. 2015;15:258.CrossRef
14.
Llenas-Garcia J, Wikman-Jorgensen P, Hobbins M, et al. Retention in care of HIV-infected pregnant and lactating women starting ART under Option B+ in rural Mozambique. Trop Med Int Health. 2016;21(8):1003–12.PubMedCrossRef
15.
Dzangare J, Takarinda KC, Harries AD, et al. HIV testing uptake and retention in care of HIV-infected pregnant and breastfeeding women initiated on ‘Option B+ ’ in rural Zimbabwe. Trop Med Int Health. 2016;21(2):202–9.PubMedCrossRef
16.
Erlwanger AS, Joseph J, Gotora T, et al. Patterns of hiv care clinic attendance and adherence to antiretroviral therapy among pregnant and breastfeeding women living With HIV in the context of Option B+ in Zimbabwe. J Acquir Immune Defic Syndr. 2017;75(Suppl 2):S198–s206.PubMedCrossRef
17.
Clouse K, Schwartz S, Van Rie A, Bassett J, Yende N, Pettifor A. “What they wanted was to give birth; nothing else”: barriers to retention in option B+ HIV care among postpartum women in South Africa. J Acquir Immune Defic Syndr. 2014;67(1):e12–8.PubMedPubMedCentralCrossRef
18.
Gugsa S, Potter K, Tweya H, et al. Exploring factors associated with ART adherence and retention in care under Option B+ strategy in Malawi: a qualitative study. PLoS ONE. 2017;12(6):e0179838.PubMedPubMedCentralCrossRef
19.
Kim MH, Mazenga A, Simon K, Yu X, Ahmed S, Nyasulu P, et al. Burnout and self-reported suboptimal patient care amongst health care workers providing HIV care in Malawi. Hum Resour Health. 2017;13:e0192983.
20.
Ahmed S, Kim MH, Abrams EJ. Risks and benefits of lifelong antiretroviral treatment for pregnant and breastfeeding women: a review of the evidence for the Option B+ approach. Curr Opin HIV AIDS. 2013;8(5):473–88.CrossRef
21.
Kim MH, Ahmed S, Buck WC, et al. The Tingathe programme: a pilot intervention using community health workers to create a continuum of care in the prevention of mother to child transmission of HIV (PMTCT) cascade of services in Malawi. J Int AIDS Soc. 2012;15(Suppl 2):17389.PubMedPubMedCentralCrossRef
22.
Kanters S, Park JJ, Chan K, et al. Use of peers to improve adherence to antiretroviral therapy: a global network meta-analysis. J Int AIDS Soc. 2016;19(1):21141.PubMedPubMedCentralCrossRef
23.
Sweat M, O’Donnell C, O’Donnell L. Cost-effectiveness of a brief video-based HIV intervention for African American and Latino sexually transmitted disease clinic clients. AIDS. 2001;15(6):781–7.PubMedCrossRef
24.
Chiasson MA, Shaw FS, Humberstone M, Hirshfield S, Hartel D. Increased HIV disclosure three months after an online video intervention for men who have sex with men (MSM). AIDS Care. 2009;21(9):1081–9.PubMedCrossRef
25.
Tuong W, Larsen ER, Armstrong AW. Videos to influence: a systematic review of effectiveness of video-based education in modifying health behaviors. J Behav Med. 2014;37(2):218–33.CrossRefPubMed
26.
Wong IY, Lawrence NV, Struthers H, McIntyre J, Friedland GH. Development and assessment of an innovative culturally sensitive educational videotape to improve adherence to highly active antiretroviral therapy in Soweto, South Africa. J Acquir Immune Defic Syndr. 2006;43(Suppl 1):S142–8.PubMedCrossRef
27.
Fisher HH, Patel-Larson A, Green K, et al. Evaluation of an HIV prevention intervention for African Americans and Hispanics: findings from the VOICES/VOCES Community-based Organization Behavioral Outcomes Project. AIDS Behav. 2011;15(8):1691–706.PubMedCrossRef
28.
Neumann MS, O’Donnell L, Doval AS, et al. Effectiveness of the VOICES/VOCES sexually transmitted disease/human immunodeficiency virus prevention intervention when administered by health department staff: does it work in the “real world”? Sex Transm Dis. 2011;38(2):133–9.PubMedCrossRef
29.
Sobel RM, Paasche-Orlow MK, Waite KR, Rittner SS, Wilson EA, Wolf MS. Asthma 1-2-3: a low literacy multimedia tool to educate African American adults about asthma. J Commun Health. 2009;34(4):321–7.CrossRef
30.
Israel BA, Schulz AJ, Parker EA, Becker AB. Community-based participatory research: policy recommendations for promoting a partnership approach in health research. Educ Health (Abingdon, England). 2001;14(2):182–97.CrossRef
31.
Rhodes SD, Hergenrather KC, Montano J, et al. Using community-based participatory research to develop an intervention to reduce HIV and STD infections among Latino men. IADS Educ Prev. 2006;18(5):375–89.CrossRef
32.
Bandura A. Social foundations of thought and action: a social cognitive theory. Englewood Cliffs: Prentice-Hall; 1986.
33.
Ajzen I. The theory of planned behavior. Organ Behav Hum Decis Process. 1991;50(2):179–211.CrossRef
34.
Fisher JD, Fisher WA, Amico KR, Harman JJ. An information-motivation-behavioral skills model of adherence to antiretroviral therapy. Health Psychol. 2006;25(4):462–73.PubMedCrossRef
35.
Jensen JD. The relative persuasiveness of gain-framed loss-framed messages for encouraging disease prevention behaviors: a meta-analytic review AU - O’Keefe, Daniel J. J Health Commun. 2007;12(7):623–44.PubMedCrossRef
36.
Kim MH, Zhou A, Mazenga A, et al. Why Did I Stop? Barriers and Facilitators to Uptake and Adherence to ART in Option B+ HIV Care in Lilongwe, Malawi. PLoS ONE. 2016;11(2):e0149527.PubMedPubMedCentralCrossRef
37.
The World Bank. World Bank Online Data. 2018.
38.
ICAP. Malawi Population-Based HIV Impact Assessment: MPHIA 2015–2016.; 2016.
39.
National Statistical Office Malawi, ICF International. Malawi Demographic and Health Survey 2015-16: Key Indicators Report. Zomba, Malawi; 2016.
40.
Malawi Ministry of Health. Clinical Management of HIV in Children and Adults. 3rd ed. Lilongwe: Malawi Ministry of Health; 2016.
41.
42.
Zimet GD, Dahlem NW, Zimet SG, Farley GK. The Multidimensional Scale of Perceived Social Support Journal of Personality Assessment. 1988;52(1):30–41.
43.
World Health Organization. WHO Violence Against Women Instrument. 2003.
44.
Saunder JB, Aasland OG, Babor TF, De La Fuente JR, Grant M. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption-II. Addiction. 1993;88(6):791–804.CrossRef
45.
Berman AH, Bergman H, Palmstierna T, Schlyter F. Evaluation of the Drug Use Disorders Identification Test (DUDIT) in criminal justice and detoxification settings and in a Swedish population sample. Eur Addict Res. 2005;11(1):22–31.PubMedCrossRef
46.
Stewart RC, Kauye F, Umar E, et al. Validation of a Chichewa version of the self-reporting questionnaire (SRQ) as a brief screening measure for maternal depressive disorder in Malawi, Africa. J Affect Disord. 2009;112(1–3):126–34.PubMedCrossRef
47.
Stewart RC, Umar E, Tomenson B, Creed F. Validation of the multi-dimensional scale of perceived social support (MSPSS) and the relationship between social support, intimate partner violence and antenatal depression in Malawi. BMC Psychiatry. 2014;14:180.PubMedPubMedCentralCrossRef
48.
Seth P, Glenshaw M, Sabatier JHF, et al. AUDIT, AUDIT-C, and AUDIT-3: drinking Patterns and Screening for Harmful, Hazardous and Dependent Drinking in Katutura, Namibia. PLoS ONE. 2015;10(3):e0120850.PubMedPubMedCentralCrossRef
49.
Berman AH BH PT, Schlyter F. The Drug Use Disorders Identification Test (DUDIT) Manual. 1.0 ed. Stockholm: Karolinska Institutet, Department of Clinical Neuroscience, Section for Alcohol and Drug Dependence Research; 2003.
50.
Love EM, Manalo IF, Chen SC, Chen KH, Stoff BK. A video-based educational pilot for basal cell carcinoma (BCC) treatment: a randomized controlled trial. J Am Acad Dermatol. 2016;74(3):477–83.e7.PubMedCrossRef
51.
Myer L, Phillips TK, Zerbe A, et al. Optimizing antiretroviral therapy (ART) for maternal and child health (MCH): rationale and design of the MCH-ART Study. J Acquir Immune Defic Syndr. 2016;72(Suppl 2):S189–96.PubMedPubMedCentralCrossRef
52.
Johnson MO, Neilands TB, Dilworth SE, Morin SF, Remien RH, Chesney MA. The role of self-efficacy in HIV treatment adherence: validation of the HIV Treatment Adherence Self-Efficacy Scale (HIV-ASES). J Behav Med. 2007;30(5):359–70.PubMedPubMedCentralCrossRef
53.
Phillips T, Brittain K, Mellins CA, et al. A self-reported adherence measure to screen for elevated HIV viral load in pregnant and postpartum women on antiretroviral therapy. AIDS Behav. 2017;21(2):450–61.PubMedPubMedCentralCrossRef
54.
International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. ICH Harmonised Tripartite Guideline: Statistical Principles for Clinical Trials E9. ICH Harmonised Tripartite Guideline: Statistical Principles for Clinical Trials. European Medicines Agency. 1998.
55.
Hess LM, Raebel MA, Conner DA, Malone DC. Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures. Ann Pharmacother. 2006;40(7–8):1280–8.PubMedCrossRef
56.
Ortego C, Huedo-Medina TB, Llorca J, et al. Adherence to highly active antiretroviral therapy (HAART): a meta-analysis. AIDS Behav. 2011;15(7):1381–96.PubMedCrossRef
Metadata
Title
VITAL Start: Video-Based Intervention to Inspire Treatment Adherence for Life—Pilot of a Novel Video-Based Approach to HIV Counseling for Pregnant Women Living with HIV
Authors
Maria H. Kim
Saeed Ahmed
Tapiwa Tembo
Rachael Sabelli
Robert Flick
Xiaoying Yu
Alick Mazenga
Holly Le Blond
Katie Simon
Miriam Hartig
Elizabeth Wetzel
Rose Nyirenda
Peter N. Kazembe
Mtisunge Mphande
Angella Mkandawire
Mike J. Chitani
Elaine J. Abrams
Publication date
01-11-2019
Publisher
Springer US
Published in
AIDS and Behavior / Issue 11/2019
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-019-02634-1

Other articles of this Issue 11/2019

AIDS and Behavior 11/2019 Go to the issue

Original Paper

HIV Testing and ART Adherence Among Unstably Housed Black Men Who Have Sex with Men in the United States

Original Paper

Psychosocial Factors Associated with Food Insufficiency Among People Living with HIV/AIDS (PLWH) Initiating ART in Ethiopia

Original Paper

Effects of a Mobile Health Intervention to Promote HIV Self-testing with MSM in China: A Randomized Controlled Trial

Original Paper

Disparities in Viral Suppression and Medication Adherence among Women in the USA, 2011–2016

Original Paper

Metabolic Syndrome Among People Living with HIV Receiving Medical Care in Southern United States: Prevalence and Risk Factors

Original Paper

Age, Sex, Race, Ethnicity, Sexual Orientation: Intersectionality of Marginalized-Group Identities and Enacted HIV-Related Stigma Among People Living with HIV in Florida
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits